A gluten-free diet is currently the only reliable therapeutic strategy that is approved for coeliac disease (CD). For many patients, however, compliance remains inadequate.
Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge / Mandile, R; Picascia, Stefania; Parrella, Claudia; Camarca, Alessandra; Gobbetti, M; Greco, Luigi; Troncone, Riccardo; Gianfrani, Carmela; Auricchio, Renata. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 46:4(2017), pp. 440-446-446. [10.1111/apt.14175]
Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge
Mandile, R;PICASCIA, STEFANIA;PARRELLA, CLAUDIA;CAMARCA, ALESSANDRA;GRECO, LUIGI;TRONCONE, RICCARDO;GIANFRANI, CARMELA;AURICCHIO, RENATA
2017
Abstract
A gluten-free diet is currently the only reliable therapeutic strategy that is approved for coeliac disease (CD). For many patients, however, compliance remains inadequate.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
